These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 9397657)

  • 1. Oral treatment options for onychomycosis.
    Joseph WS
    J Am Podiatr Med Assoc; 1997 Nov; 87(11):520-31. PubMed ID: 9397657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacoeconomic approach to onychomycosis therapy].
    Glad'ko VV; Tarasenko GN
    Voen Med Zh; 2002 Jun; 323(6):54-5. PubMed ID: 12140994
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis.
    Gupta AK
    Pharmacoeconomics; 1998 Feb; 13(2):243-56. PubMed ID: 10178650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onychomycosis: improved cure rates with itraconazole and terbinafine.
    Harrell TK; Necomb WW; Replogle WH; King DS; Noble SL
    J Am Board Fam Pract; 2000; 13(4):268-73. PubMed ID: 10933291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of dermatophyte toenail onychomycosis in the United States. A pharmacoeconomic analysis.
    Gupta AK
    J Am Podiatr Med Assoc; 2002 May; 92(5):272-86. PubMed ID: 12015408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating onychomycosis.
    Rodgers P; Bassler M
    Am Fam Physician; 2001 Feb; 63(4):663-72, 677-8. PubMed ID: 11237081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action.
    Rosen T; Stein Gold LF
    Semin Cutan Med Surg; 2016 Mar; 35(3 Suppl 3):S51-5. PubMed ID: 27074700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cost/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: griseofulvin, itraconazole, and terbinafine.
    Angello JT; Voytovich RM; Jan SA
    Am J Manag Care; 1997 Mar; 3(3):443-50. PubMed ID: 10173095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails.
    Casciano J; Amaya K; Doyle J; Arikian S; Shear N; Haspel M; Kahler K
    Manag Care; 2003 Mar; 12(3):47-54. PubMed ID: 12685377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany.
    Van Doorslaer EK; Tormans G; Gupta AK; Van Rossem K; Eggleston A; Dubois DJ; De Doncker P; Haneke E
    Dermatology; 1996; 193(3):239-44. PubMed ID: 8944348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
    Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR
    J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacoeconomic analysis of the new oral antifungal agents used to treat toenail onychomycosis in the USA.
    Gupta AK; Lambert J
    Int J Dermatol; 1999 Sep; 38 Suppl 2():53-64. PubMed ID: 10515529
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost effectiveness of continuous terbinafine compared with intermittent itraconazole in the treatment of dermatophyte toenail onychomycosis: an analysis of based on results from the L.I.ON. study. Lamisil versus Itraconazole in Onychomycosis.
    Jansen R; Redekop WK; Rutten FF
    Pharmacoeconomics; 2001; 19(4):401-10. PubMed ID: 11383756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral therapeutic agents in fungal nail disease.
    Roberts DT
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S78-81. PubMed ID: 8077514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onychomycosis--a different perspective.
    Epstein E
    West J Med; 1997 Jul; 167(1):52-3. PubMed ID: 9265870
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of onychomycosis in children.
    Gupta AK; De Rosso JQ
    Postgrad Med; 1999 Jul; Spec No():31-7. PubMed ID: 10492664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapies for the treatment of onychomycosis.
    Gupta AK; Paquet M; Simpson FC
    Clin Dermatol; 2013; 31(5):544-54. PubMed ID: 24079583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Itraconazole and terbinafine in perspective. From petri dish to patient.
    De Doncker P; Gupta AK
    Postgrad Med; 1999 Jul; Spec No():6-11. PubMed ID: 10492660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contempo 1997: dermatology.
    Del Rosso JQ
    JAMA; 1997 Oct; 278(14):1148; author reply 1149. PubMed ID: 9326467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.